BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12847244)

  • 1. Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1.
    Ioannidis V; Kunz B; Tanamachi DM; Scarpellino L; Held W
    J Immunol; 2003 Jul; 171(2):769-75. PubMed ID: 12847244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells.
    Kunz B; Held W
    J Immunol; 2001 May; 166(10):6181-7. PubMed ID: 11342639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1.
    Held W; Kunz B; Lowin-Kropf B; van de Wetering M; Clevers H
    Immunity; 1999 Oct; 11(4):433-42. PubMed ID: 10549625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles.
    Gosselin P; Lusignan Y; Brennan J; Takei F; Lemieux S
    Int Immunol; 1997 Apr; 9(4):533-40. PubMed ID: 9138013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition.
    Held W; Clevers H; Grosschedl R
    Eur J Immunol; 2003 May; 33(5):1393-8. PubMed ID: 12731066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell inhibitory receptor Ly-49C residues involved in MHC class I binding.
    Sundbäck J; Achour A; Michaëlsson J; Lindström H; Kärre K
    J Immunol; 2002 Jan; 168(2):793-800. PubMed ID: 11777974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
    Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
    J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing.
    Makrigiannis AP; Rousselle E; Anderson SK
    J Immunol; 2004 Feb; 172(3):1414-25. PubMed ID: 14734717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.
    Brennan J; Mager D; Jefferies W; Takei F
    J Exp Med; 1994 Dec; 180(6):2287-95. PubMed ID: 7964501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
    Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
    Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
    Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
    Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice.
    Karlhofer FM; Orihuela MM; Yokoyama WM
    J Exp Med; 1995 May; 181(5):1785-95. PubMed ID: 7722455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands.
    Silver ET; Lavender KJ; Gong DE; Hazes B; Kane KP
    J Immunol; 2002 Nov; 169(9):4752-60. PubMed ID: 12391184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential survival of CD8 T and NK cells expressing high levels of CD94.
    Gunturi A; Berg RE; Forman J
    J Immunol; 2003 Feb; 170(4):1737-45. PubMed ID: 12574337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control.
    Korten S; Volkmann L; Saeftel M; Fischer K; Taniguchi M; Fleischer B; Hoerauf A
    J Immunol; 2002 May; 168(10):5199-206. PubMed ID: 11994476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ly-49D receptor activates murine natural killer cells.
    Mason LH; Anderson SK; Yokoyama WM; Smith HR; Winkler-Pickett R; Ortaldo JR
    J Exp Med; 1996 Dec; 184(6):2119-28. PubMed ID: 8976168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.